STTKShattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a de…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy? Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out. | ||
 Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade The consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. | ||
 Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday An analyst initiated coverage of the biotech with a buy recommendation. | ||
 SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls | TThe Fly | |
 Here Are Friday’s Top Wall Street Analyst Research Calls: Albertsons, Blue Owl Capital, Cleveland-Cliffs, Chime Financial, Digital Realty, Dover, PayPal Holdings, SpaceX, and More Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions sent every major index deep into the red. See which stocks analysts are upgrading, downgrading, and initiating fresh coverage on as Wall Street braces for more turbulence. | ||
Netflix upgraded, Microsoft initiated: Wall Street's top analyst calls Netflix upgraded, Microsoft initiated: Wall Street's top analyst calls | TThe Fly | |